Abstract
We report 7 rare cases of recurrent breast cancers who presented with central nervous system (CNS) metastases as the initial relapse site without any other organ metastases. The average age of the patients at surgery was 42.6 years old of age (median 45: range 32-60), and 6 of the 7 cases (86%) were premenopausal. The mean disease-free period was 25.7 months (median 22, range 2-60 months). The primary tumors were all invasive ductal carcinomas. The estrogen receptor and progesterone receptor status of the 3 tumors available for study were all negative. The metastatic CNS lesions included the cerebrum (4 cases), cerebellum, cervical spinal cord, and meninges. In 6 out of these 7 cases (86%), the CNS metastasis was the initial recurrent lesion. Multidisciplinary treatments including surgery, radiotherapy and systemic or intrathecal chemotherapy were given. Although the mean survival time from clinical manifestations of the metastases of the 4 deceased patients was 20 months (median 20.5; range 6-33), one patient treated with surgery and radiotherapy is been still alivel 8 years later. These cases were also notable for the fact that the only metastatic site was in the CNS only during the entire clinical course, except for 2 cases, one with ocular adnexa metastasis, and the other with cervical lymph node metastasis. Premenopausal patients with negative hormone receptor status are more likely to develop this type of recurrence, regardless of the histological type. It is necessary to pay attention to neurological symptoms and signs during follow-up of breast cancer patients.
Similar content being viewed by others
Abbreviations
- CNS:
-
Central nervous system
- ER:
-
Estrogen receptor
- PgR:
-
Progesterone receptor
- CPA:
-
Cyclophosphamide
- ADM:
-
Adriamycin
- MTX:
-
Methotrexate
- 5FU:
-
5-fluorouracil
- TAM:
-
Tamoxifen
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
References
Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy.Cancer 41:1170–1178, 1978.
Glass JP, Foley KM: Brain metastases in patients with breast cancer. In: Harris JR, Lippman ME,et al eds, Diseases of the Breast, Lippincott-Raven Publishers, Philadelphia, pp769–779, 1996.
Jayson GC, Howell A, Harris M,et al: Carcinomatous meningitis in patients with breast cancer.Cancer 74:3135–3141, 1994.
Sparrow GEA, Rubens RD: Brain metastases from breast cancer: clinical course, prognosis, and influence on treatment.Clin Oncol 7:291–301, 1981.
Boogerd W, Dalesio 0, Bais EM,et al: Response of brain metastases from breast cancer to systemic chemotherapy.Cancer 69:972–980, 1992.
Stewart JF, King RJ, Sexton SA,et al: Oestrogen receptors, site of metastatic disease, and survival in recurrent breast cancer.Eur J Cancer Clin Oncol 17:449–453, 1981.
Yamamoto N, Watanabe T, Katsumata N,et al: Construction and validation of a practical prognostic index for patients with metastatic breast cancer.J Clin Oncol 16:2401–2408, 1998.
Harris M, Howell A, Chrissohou M,et al: A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast.Br J Cancer 50:23–30, 1984.
Dixon AR, Ellis IO, Elston CW,et al: A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinoma of the breast.Br J Cancer 63:634–635, 1991.
Lemovec J, Bracko M: Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy study.J Surg Oncol 48:28–33, 1991.
Jain S, Fisher C, Smith P,et al: Patterns of metastatic breast cancer in relation to histologic type.Eur J Cancer 29A:2155–2157, 1993.
Gamel JW, Keeney AH: Metastasis to the eye and ocular adnexa. In: Donegan WL, Spratt JS eds, Cancer of the Breast, 4th ed, W.B. Saunders Company, pp712–716, 1995.
Riley FG: Metastatic tumors of the eyelids.Am J Ophthalmol 69:259–264, 1970.
Del Turco MR, Palli D, Cariddi A,et al: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial.JAMA 271:1593–1597, 1994.
The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial.JAMA 271:1587–1592, 1994.
Fukutomi T: Breast carcinoma: counterpoint. In: Johnson SE, Virgo KS eds, Cancer Patient Follow-up, 1st ed, Mosby, St lous, pp315–319, 1997.
Author information
Authors and Affiliations
About this article
Cite this article
Higashi, H., Fukutomi, T., Watanabe, T. et al. Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases. Breast Cancer 7, 153–156 (2000). https://doi.org/10.1007/BF02967448
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967448